Combined surgical approach for chronic anal fissure
Official title: Combined Method of Surgical Treatment of Anal Fissure
Run by State Scientific Centre of Coloproctology, Russian Federation · NCT07268261 · Data updated 2026-11-12
This trial tries removing the fissure and giving botulinum toxin A to relax the internal anal sphincter in people with chronic anal fissure to reduce pain, recurrence, and sphincter problems.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 122 (estimated) |
| Sponsor | State Scientific Centre of Coloproctology, Russian Federation Government |
| Locations | 1 site (Moscow) |
| Status | Recruiting |
| Started | September 1, 2023 |
| Main results expected | December 1, 2025 |
| Study ends | September 1, 2026 |
| Registry record updated | December 5, 2025 |
| Trial ID | NCT07268261 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with chronic anal fissure lasting more than two months with documented internal sphincter spasm and without exclusion conditions such as inflammatory bowel disease, prior anal canal surgery, significant sphincter insufficiency, pregnancy, or contraindications to botulinum toxin are ideal candidates.
✕Probably not a fit
Patients with active inflammatory bowel disease, existing anal sphincter insufficiency, prior anal surgeries, pregnancy, lactation, or known hypersensitivity to botulinum toxin are unlikely to be eligible or to receive benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center interventional program tests a combined surgical approach for chronic anal fissure that pairs fissure excision with postoperative injection of botulinum toxin A to relax the internal anal sphincter. The rationale is that sphincter spasm underlies chronic fissures and that botulinum toxin may reduce postoperative sphincter hypertonia, lowering pain and the risk or duration of sphincter insufficiency. Participants are adults with chronic fissures and internal sphincter spasm who meet exclusion criteria such as inflammatory bowel disease, prior anal surgery, significant sphincter insufficiency, pregnancy, or contraindications to botulinum toxin. The study is conducted at the State Scientific Centre of Coloproctology in Moscow and uses surgical excision followed by botulinum toxin as the interventional protocol; outcomes likely include pain, healing, recurrence, and incontinence though specific endpoints are not listed in the registry entry.
Why it matters
Potential benefit: If successful, this approach could speed healing and reduce postoperative pain, recurrence, and the frequency or duration of sphincter-related incontinence.
How similar studies have gone: Botulinum toxin A has been used with modest success as a non-surgical treatment for chronic anal fissure, but combining fissure excision with immediate botulinum injection is less extensively studied and is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Patients with chronic anal fissure with spasm of anal sphincter Exclusion Criteria: * • Inflammatory diseases of the colon * Pectenosis * Previous surgical interventions on the anal canal * IV grade internal and external hemorrhoids * Rectal fistula * Severe somatic diseases at the decompensation stage * Pregnancy and lactation * Anal sphincter insufficiency * Chronic paraproctitis * Individual intolerance and hypersensitivity to botulinum toxin * Myasthenia gravis and myasthenic syndromes * History of allergic reaction to anticoagulants. * Blood diseases (thrombocytopenia, splenomegaly, etc.)
Where it's running
-
SSCCRussia
Moscow, Russia Recruiting
Study contacts
- Principal investigator: Sergey A. Frolov, Ph.D — State Scientific Centre of Coloproctology, Russian Federation (SSCCRussia)
- Study coordinator: Evgeny E. Zharkov, MD
- Email: drzharkov@mail.ru
- Phone: +79039689739
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
AI-assisted written information to support treatment for chronic anal fissure
This trial compares AI-assisted written information to standard verbal counseling to see if people with a chronic anal fissure better stick with initial medical treatment.
-
Three LIS techniques for chronic anal fissure healing
This trial tests three different ways of performing lateral internal sphincterotomy to see which best heals chronic anal fissures with the least risk of incontinence.
-
Treatment for chronic anal fissures using E-CEL UVEC cells
This study is testing if injections of special cells can help people with chronic anal fissures who haven't found relief from regular treatments.
-
Ultrasound-based look at how much sphincter is cut during LIS for chronic anal fissure
This study tests whether the amount of internal anal sphincter divided during lateral internal sphincterotomy affects healing and continence in adults with chronic anal fissure.
-
Botox injections alone vs with fissurectomy and anoplasty for chronic anal fissure
This study tests whether adding fissurectomy and anoplasty to Botox injections helps healing and pain relief for adults with chronic anal fissure.
-
Improving recovery after surgery for benign anorectal conditions
This study is testing if a special recovery plan can help people aged 18 to 65 have fewer problems with urinary retention after surgery for conditions like hemorrhoids and anal fissures.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.